Market Tracker

12/19 11:01pm ET

Ligand Pharmaceuticals Inc (NASDAQ:LGND)

52.32
Data as of Dec 19
 +0.19 / +0.36%
Today’s Change
41.99
Today|||52-Week Range
80.42
-0.53%
Year-to-Date
No recent news for Ligand Pharmaceuticals Inc.

Today’s Trading

Previous close52.13
Today’s open52.04
Day’s range51.91 - 53.11
Volume750,988
Average volume (3 months)370,075
Market cap$1.0B
Dividend yield--
Data as of 4:00pm ET, 12/19/2014

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+68.89%
Earnings growth (next 5 years)+30.00%
Revenue growth (last year)+56.02%
P/E ratio158.5
Price/Sales21.82
Price/Book21.59

Competitors

 Today’s
change
Today’s
% change
SAGESAGE Therapeutics In...-0.13-0.32%
EBSEmergent BioSolution...+0.07+0.26%
FWPForward Pharma A/S+0.76+3.68%
MGNXMacroGenics Inc+0.70+2.07%
Data as of 4:05pm ET, 12/19/2014

Financials

Next reporting dateFebruary 10, 2015
EPS forecast (this quarter)$0.60
Annual revenue (last year)$49.0M
Annual profit (last year)$8.8M
Net profit margin18.03%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John L. Higgins
Chief Operating Officer &
Executive Vice President
Matthew W. Foehr
Corporate headquarters
La Jolla, California

Forecasts